Sirona Biochem Corp.
SBM.V
TSX
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -109.87% | 43.18% | -16.61% | -17.99% | 30.14% |
| Total Depreciation and Amortization | 5.56% | 0.00% | -5.26% | -70.31% | 328.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 215.09% | -178.79% | 1,776.32% | -93.45% | 515.59% |
| Change in Net Operating Assets | -172.13% | 116.58% | -154.58% | 208.49% | -502.27% |
| Cash from Operations | 20.32% | -25.90% | -125.76% | 55.92% | 27.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 25.55% | 355.86% | -78.39% | 762.71% | -104.21% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -66.61% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.52% | 609.11% | -76.09% | 690.97% | -103.94% |
| Foreign Exchange rate Adjustments | 1,400.00% | 125.00% | -100.36% | 27,550.00% | -130.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.55% | 81.60% | -275.90% | 143.07% | -179.62% |
